关注
Andrew Prayle
Andrew Prayle
在 nottingham.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Compliance with mandatory reporting of clinical trial results on ClinicalTrials. gov: cross sectional study
AP Prayle, MN Hurley, AR Smyth
Bmj 344, 2012
3562012
Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis
A Prayle, A Watson, H Fortnum, A Smyth
Thorax 65 (7), 654-658, 2010
1902010
Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity
A Prayle, AR Smyth
Current opinion in pulmonary medicine 16 (6), 604-610, 2010
1252010
Pneumonia in the developed world
A Prayle, M Atkinson, A Smyth
Paediatric respiratory reviews 12 (1), 60-69, 2011
1012011
Rate of improvement of CF life expectancy exceeds that of general population—observational death registration study
MN Hurley, TM McKeever, AP Prayle, AW Fogarty, AR Smyth
Journal of Cystic Fibrosis 13 (4), 410-415, 2014
952014
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
MN Hurley, AP Prayle, P Flume
Cochrane Database of Systematic Reviews, 2015
472015
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
MN Hurley, S Smith, DL Forrester, AR Smyth
Cochrane Database of Systematic Reviews, 2020
432020
Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging
C Ng, NS Dellschaft, CL Hoad, L Marciani, L Ban, AP Prayle, HL Barr, ...
Journal of Cystic Fibrosis 20 (4), 591-597, 2021
402021
Karyomegalic-like nephropathy, Ewing’s sarcoma and ifosfamide therapy
T McCulloch, A Prayle, A Lunn, AR Watson
Pediatric nephrology 26, 1163-1166, 2011
312011
Association between treatments and short-term biochemical improvements and clinical outcomes in post-severe acute respiratory syndrome coronavirus-2 inflammatory syndrome
P Davies, J Lillie, A Prayle, C Evans, B Griffiths, P du Pré, M Johnson, ...
Pediatric Critical Care Medicine 22 (5), e285-e293, 2021
292021
Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD
M John, S Hussain, A Prayle, R Simms, JR Cockcroft, CE Bolton
Respiratory Research 14, 1-7, 2013
282013
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison
AP Prayle, K Jain, DJ Touw, BCP Koch, AJ Knox, A Watson, AR Smyth
Journal of Cystic Fibrosis 15 (4), 510-517, 2016
272016
Growth and nutrition in children with ataxia telangiectasia
E Stewart, AP Prayle, A Tooke, S Pasalodos, M Suri, A Bush, JM Bhatt
Archives of disease in childhood 101 (12), 1137-1141, 2016
202016
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
PR Burgel, KW Southern, C Addy, A Battezzati, C Berry, JP Bouchara, ...
Journal of Cystic Fibrosis 23 (2), 187-202, 2024
182024
Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review
NJ Rowbotham, S Smith, AP Prayle, KA Robinson, AR Smyth
Thorax 74 (3), 229-236, 2019
172019
Bronchopulmonary dysplasia prediction models: a systematic review and meta-analysis with validation
TC Kwok, N Batey, KL Luu, A Prayle, D Sharkey
Pediatric Research 94 (1), 43-54, 2023
122023
β2-agonists do not work in children under 2 years of age: myth or maxim?
F Yusuf, AP Prayle, MP Yanney
Breathe 15 (4), 273-276, 2019
122019
Delayed publication of clinical trials in cystic fibrosis
MN Hurley, AP Prayle, AR Smyth
Journal of Cystic Fibrosis 11 (1), 14-17, 2012
102012
Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis
AP Prayle, MN Hurley, AR Smyth
Cochrane Database of Systematic Reviews, 2010
82010
Gastrointestinal complications of cystic fibrosis
C Ng, AP Prayle
Paediatrics and Child Health 30 (10), 345-349, 2020
72020
系统目前无法执行此操作,请稍后再试。
文章 1–20